Article (Périodiques scientifiques)
SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg
WILMES, Paul; ZIMMER, Jacques; Schulz, Jasmin et al.
2021In The Lancet Regional Health. Europe, 4, p. 100056
Peer reviewed vérifié par ORBi
 

Documents


Texte intégral
Wilmes_LST_Lancet_Europe_2021.pdf
Postprint Éditeur (2.36 MB)
Demander un accès

Tous les documents dans ORBilu sont protégés par une licence d'utilisation.

Envoyer vers



Détails



Mots-clés :
Asymptomatic; Contact tracing; COVID-19; Mass screening; rRT-PCR; SARS-CoV-2
Résumé :
[en] Background To accompany the lifting of COVID-19 lockdown measures, Luxembourg implemented a mass screening (MS) programme. The first phase coincided with an early summer epidemic wave in 2020. Methods rRT-PCR-based screening for SARS-CoV-2 was performed by pooling of samples. The infrastructure allowed the testing of the entire resident and cross-border worker populations. The strategy relied on social connectivity within different activity sectors. Invitation frequencies were tactically increased in sectors and regions with higher prevalence. The results were analysed alongside contact tracing data. Findings The voluntary programme covered 49 of the resident and 22 of the cross-border worker populations. It identified 850 index cases with an additional 249 cases from contact tracing. Over-representation was observed in the services, hospitality and construction sectors alongside regional differences. Asymptomatic cases had a significant but lower secondary attack rate when compared to symptomatic individuals. Based on simulations using an agent-based SEIR model, the total number of expected cases would have been 42·9 (90 CI [-0·3, 96·7]) higher without MS. Mandatory participation would have resulted in a further difference of 39·7 [19·6, 59·2]. Interpretation Strategic and tactical MS allows the suppression of epidemic dynamics. Asymptomatic carriers represent a significant risk for transmission. Containment of future outbreaks will depend on early testing in sectors and regions. Higher participation rates must be assured through targeted incentivisation and recurrent invitation. Funding This project was funded by the Luxembourg Ministries of Higher Education and Research, and Health.
Disciplines :
Immunologie & maladie infectieuse
Auteur, co-auteur :
WILMES, Paul ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Systems Ecology
ZIMMER, Jacques ;  University of Luxembourg > Faculty of Science, Technology and Communication (FSTC)
Schulz, Jasmin
Glod, Frank
Veiber, Lisa
MOMBAERTS, Laurent ;  University of Luxembourg
Rodrigues, Bruno
AALTO, Atte ;  University of Luxembourg
Pastore, Jessica
Snoeck, Chantal J.
OLLERT, Markus ;  University of Luxembourg
FAGHERAZZI, Guy ;  University of Luxembourg
MOSSONG, Joel ;  University of Luxembourg > Faculty of Science, Technology and Communication (FSTC)
GONCALVES, Jorge ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Systems Control
SKUPIN, Alexander  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Integrative Cell Signalling
NEHRBASS, Ulf ;  University of Luxembourg
Plus d'auteurs (6 en +) Voir moins
Co-auteurs externes :
yes
Langue du document :
Anglais
Titre :
SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg
Date de publication/diffusion :
2021
Titre du périodique :
The Lancet Regional Health. Europe
eISSN :
2666-7762
Maison d'édition :
Elsevier, Oxford, Royaume-Uni
Volume/Tome :
4
Pagination :
100056
Peer reviewed :
Peer reviewed vérifié par ORBi
Disponible sur ORBilu :
depuis le 01 août 2022

Statistiques


Nombre de vues
260 (dont 1 Unilu)
Nombre de téléchargements
0 (dont 0 Unilu)

citations Scopus®
 
74
citations Scopus®
sans auto-citations
63
OpenCitations
 
50
citations OpenAlex
 
96
citations WoS
 
66

Bibliographie


Publications similaires



Contacter ORBilu